EGFR and hepatocellular carcinoma: In our study, we showed that dual inhibition of mTOR and EGFR induced a synergistic antiproliferative effect in the PI3KCA and PTEN-mutant CAL-51 cell line, but not in the PTEN-null HCC-1937 cell line.